Edgestream Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,181
| Closed | -$383K | – | 1079 |
|
|
2026
Q1 | $383K | Sell |
3,181
-19,845
| -86% | -$2.29M | 0.01% | 773 |
|
|
2025
Q4 | $2.42M | Sell |
23,026
-23,311
| -50% | -$2.19M | 0.07% | 478 |
|
|
2025
Q3 | $3.89M | Buy |
46,337
+11,130
| +32% | +$917K | 0.11% | 340 |
|
|
2025
Q2 | $2.79M | Buy |
35,207
+5,049
| +17% | +$401K | 0.08% | 453 |
|
|
2025
Q1 | $2.71M | Buy |
30,158
+22,263
| +282% | +$2.08M | 0.09% | 410 |
|
|
2024
Q4 | $785K | Sell |
7,895
-13,101
| -62% | -$1.35M | 0.03% | 609 |
|
|
2024
Q3 | $2.38M | Buy |
20,996
+11,246
| +115% | +$1.34M | 0.1% | 349 |
|
|
2024
Q2 | $1.21M | Buy |
+9,750
| New | +$1.26M | 0.06% | 475 |
|
|
2024
Q1 | – | Sell |
-12,351
| Closed | -$1.35M | – | 945 |
|
|
2023
Q4 | $1.35M | Buy |
12,351
+3,574
| +41% | +$371K | 0.1% | 353 |
|
|
2023
Q3 | $904K | Buy |
8,777
+5,198
| +145% | +$560K | 0.07% | 431 |
|
|
2023
Q2 | $413K | Sell |
3,579
-514
| -13% | -$58.4K | 0.04% | 566 |
|
|
2023
Q1 | $435K | Sell |
4,093
-3,589
| -47% | -$387K | 0.05% | 420 |
|
|
2022
Q4 | $852K | Sell |
7,682
-461
| -6% | -$47.1K | 0.1% | 280 |
|
|
2022
Q3 | $701K | Buy |
+8,143
| New | +$727K | 0.05% | 317 |
|
|
2022
Q2 | – | Sell |
-53,582
| Closed | -$4.4M | – | 594 |
|
|
2022
Q1 | $4.4M | Sell |
53,582
-36,707
| -41% | -$2.89M | 0.35% | 88 |
|
|
2021
Q4 | $6.92M | Buy |
90,289
+63,222
| +234% | +$5.04M | 0.43% | 52 |
|
|
2021
Q3 | $2.03M | Buy |
27,067
+18,905
| +232% | +$1.44M | 0.13% | 236 |
|
|
2021
Q2 | $635K | Sell |
8,162
-134,875
| -94% | -$10M | 0.04% | 333 |
|
|
2021
Q1 | $10.5M | Buy |
143,037
+25,212
| +21% | +$1.86M | 0.59% | 36 |
|
|
2020
Q4 | $9.2M | Buy |
+117,825
| New | +$9.01M | 0.46% | 71 |
|
|
2020
Q1 | – | Sell |
-5,312
| Closed | -$461K | – | 355 |
|
|
2019
Q4 | $461K | Sell |
5,312
-72,302
| -93% | -$5.94M | 0.02% | 275 |
|
|
2019
Q3 | $6.23M | Sell |
77,614
-47,286
| -38% | -$3.79M | 0.6% | 54 |
|
|
2019
Q2 | $9.99M | Buy |
124,900
+63,786
| +104% | +$4.88M | 1.13% | 25 |
|
|
2019
Q1 | $4.85M | Buy |
+61,114
| New | +$4.57M | 0.71% | 48 |
|
|
2017
Q3 | – | Sell |
-5,607
| Closed | -$343K | – | 137 |
|
|
2017
Q2 | $343K | Sell |
5,607
-19,919
| -78% | -$1.21M | 0.13% | 106 |
|
|
2017
Q1 | $1.55M | Buy |
25,526
+20,364
| +394% | +$1.24M | 0.68% | 33 |
|
|
2016
Q4 | $290K | Buy |
+5,162
| New | +$302K | 0.6% | 53 |
|
Other funds holding MRK
Edgestream Partners's MRK Position: Q2 2026 in Review
Edgestream Partners sold out of Merck (MRK) in Q2 2026, closing a stake of 3,181 shares — an estimated $383K sold.
Edgestream Partners first reported a position in MRK in Q4 2016 and held it in 27 quarters. The position peaked at $10.5M in Q1 2021. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Edgestream Partners reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Edgestream Partners sold 3,181 Merck shares in Q2 2026, an estimated $383K.
- Edgestream Partners first reported a position in Merck in Q4 2016 and held it in 27 quarters.
- Edgestream Partners's Merck position peaked at $10.5M in Q1 2021.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.